Design Therapeutics (DSGN) Insider Trading & Ownership → The most important AI company you've never heard of (From Manward Press) (Ad) Free DSGN Stock Alerts $4.51 +0.02 (+0.45%) (As of 05/15/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Design Therapeutics (NASDAQ:DSGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage25.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$176,820.38Number OfInsiders Selling(Last 12 Months)0 Get DSGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Design Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DSGN Insider Buying and Selling by Quarter Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth Design Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/25/2024John P SchmidDirectorBuy17,809$3.74$66,605.66 3/22/2024John P SchmidDirectorBuy9,156$3.62$33,144.72 9/29/2023Rodney W LappeDirectorBuy21,000$2.35$49,350.00 8/29/2023Deepa PrasadDirectorBuy12,000$2.31$27,720.00 (Data available from 1/1/2013 forward) DSGN Insider Trading Activity - Frequently Asked Questions Who is on Design Therapeutics's Insider Roster? The list of insiders at Design Therapeutics includes Arsani William, Deepa Prasad, Joao Md Siffert, John P Schmid, Rodney W Lappe, Simeon George, Sr One Capital Fund I Aggregat, and Stella Xu. Learn more on insiders at DSGN. What percentage of Design Therapeutics stock is owned by insiders? 25.70% of Design Therapeutics stock is owned by insiders. Learn more on DSGN's insider holdings. Which Design Therapeutics insiders have been buying company stock? The following insiders have purchased DSGN shares in the last 24 months: Deepa Prasad ($27,720.00), Joao Md Siffert ($9,740.50), John P Schmid ($99,750.38), Rodney W Lappe ($168,750.00), Simeon George ($7,246,800.00), and Sr One Capital Fund I Aggregat ($325,600.00). How much insider buying is happening at Design Therapeutics? Insiders have purchased a total of 976,115 DSGN shares in the last 24 months for a total of $7,878,360.88 bought. More Insider Trading Tools from MarketBeat Related Companies: PYXS Insider Trades TSVT Insider Trades NKTR Insider Trades ENTA Insider Trades CTMX Insider Trades XERS Insider Trades XBIT Insider Trades RAPT Insider Trades HOWL Insider Trades ALDX Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:DSGN) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Design Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.